Jaswitha, 2021 - Google Patents
Development of Metoprolol Tartrate Sustained Release Formulations by using Modified StarchesJaswitha, 2021
View PDF- Document ID
- 9135405008706179236
- Author
- Jaswitha T
- Publication year
- Publication venue
- BR Nahata Smriti Sansthan International Journal of Phramaceutical Sciences & Clinical Research
External Links
Snippet
This study is aimed to design oral sustained-release formulations for the anti-hypertension drug Metoprolol tartrate. This drug exhibits required physicochemical and pharmacokinetic parameters to formulate sustained-release formulations. The literature survey reveals that …
- 239000000203 mixture 0 title abstract description 140
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar, pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
- C08B30/12—Degraded, destructured or non-chemically modified starch, e.g. mechanically, enzymatically or by irradiation; Bleaching of starch
- C08B30/14—Cold water dispersible or pregelatinised starch
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
- A61K8/72—Cosmetic or similar toilet preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bhatt et al. | Functional and tableting properties of alkali-isolated and phosphorylated barnyard millet (Echinochloa esculenta) starch | |
| Garcia et al. | Pharmaceutical and biomedical applications of native and modified starch: a review | |
| Lawal | Modified starches as direct compression excipients–effect of physical and chemical modifications on tablet properties: A review | |
| Malik et al. | Significance of chemically derivatized starch as drug carrier in developing novel drug delivery devices | |
| JP5760069B2 (en) | Polymer hydrogel and preparation method thereof | |
| Ochubiojo et al. | Starch: from food to medicine | |
| CN103501817B (en) | Novel polysaccharide derivatives and dosage forms | |
| Charoenthai et al. | Use of modified tapioca starches as pharmaceutical excipients. | |
| Mohammed | Modified starch and its potentials as excipient in pharmaceutical formulations | |
| Olayemi et al. | Formulation and evaluation of Cyperus esculentus (Tiger Nut) starch-alginate microbeads in the oral delivery of ibuprofen | |
| Bordoloi et al. | Properties, pharmaceutical application and various technique of chemical modification in native starch: a descriptive review | |
| Paramakrishnan et al. | Effect of carboxymethylation on physicochemical, micromeritics and release characteristics of Kyllinga nemoralis starch | |
| Mori et al. | Polymers used in pharmaceutical industry for oral delivery: insight to synthesis, structure–activity relationship, and recent applications | |
| Garcia et al. | Starch applied for pharmaceutical use | |
| Jaswitha | Development of Metoprolol Tartrate Sustained Release Formulations by using Modified Starches | |
| Nigussu et al. | Acetylation and characterization of enset starch and evaluation of its direct compression and drug release sustaining properties | |
| Anwar et al. | An approach on pregelatinized cassava starch phosphate esters as hydrophilic polymer excipient for controlled release tablet | |
| JP2002511429A (en) | Sustained-release tablets prepared from linear, water-insoluble polysaccharides | |
| Meko et al. | Investigation into the use of acid modified millet (Pennisetum glaucum) starch mucilage as tablet binder | |
| Kumar et al. | Establishment of rice husk by-product as pharmaceutical excipients | |
| Sathianarayanan | Role of starch-based drug delivery system and its pharma applications | |
| JP5111753B2 (en) | Gastric retention type sustained release solid preparation | |
| Yusriadi et al. | Design and development of modified starch from Indonesian Cassava (Manihot esculenta Crantz) for enteric film coating polymer applications | |
| ES2431839T3 (en) | A chemical support based on a beta-dextrin limit | |
| Agwamba et al. | Effect of carboxymethylation on porosity and flow property of mango starch |